Legal Statement

Categories:Qijian News
Author:QIjian
Origin:QIjian
Time of issue:2022-10-31
Views:0

(Summary description)We solemnly declare:
Registered Chinese website of our company: www.qjbio.com.cn，
Registered English website of our company：www.qijianbio.com,
Contact information
Phone: 0086-431-81285900
Fax: 0086-431-88794098

Mobile: 0086-18543117394
E-mail: export@qijianbio.com
Furthermore, our company does not register or use other websites, and we also don’t authorize anyone to register or use other websites. Please distinguish truth from falsehood, beware of being cheated!





[Top]

Legal Statement

Categories:Qijian News
Author:QIjian
Origin:QIjian
Time of issue:2022-10-31
Views:0

Information

We solemnly declare:

Registered Chinese website of our company: www.qjbio.com.cn，

Registered English website of our company：www.qijianbio.com,

Contact information

Phone: 0086-431-81285900

Fax: 0086-431-88794098

Mobile: 0086-18543117394

E-mail: export@qijianbio.com

Furthermore, our company does not register or use other websites, and we also don’t authorize anyone to register or use other websites. Please distinguish truth from falsehood, beware of being cheated!

Keyword:

Scan the QR code to read on your phone

Previous: Jilin Qijian Bio-Pharmaceutical Co., Ltd. participated in the 2023CPHI Southeast Asia Exhibition

Next: Qijian Bio-pharmaceutical made a major breakthrough in the R&D of key transdermal technology using HGH analogue peptides as raw materials for medical beauty products, laying a good foundation for the company to expand the medical beauty industry in 2021.

Previous: Jilin Qijian Bio-Pharmaceutical Co., Ltd. participated in the 2023CPHI Southeast Asia Exhibition

Previous : Jilin Qijian Bio-Pharmaceutical Co., Ltd. participated in the 2023CPHI Southeast Asia Exhibition

Next : Qijian Bio-pharmaceutical made a major breakthrough in the R&D of key transdermal technology using HGH analogue peptides as raw materials for medical beauty products, laying a good foundation for the company to expand the medical beauty industry in 2021.

Previous : Jilin Qijian Bio-Pharmaceutical Co., Ltd. participated in the 2023CPHI Southeast Asia Exhibition

Next : Qijian Bio-pharmaceutical made a major breakthrough in the R&D of key transdermal technology using HGH analogue peptides as raw materials for medical beauty products, laying a good foundation for the company to expand the medical beauty industry in 2021.

Legal Statement

Legal Statement

Related News

The 2024 CPhI Milan in October is ongoing now

The 12th MEXICO-CHINA INVEST & TRADE EXPO

Welcome to the 4WE62 booth of Qijian Biopharmaceutical at CPhI Shanghai, China

Jilin Province Qijian Biotechnology Co., Ltd. participated in the international pharmaceutical technology exhibition CPHIFCE in Sao Paulo, Brazil from June 4 to 6, 2023.